A former FDA commissioner has stated that Bayer withheld data that suggested birth control drug Yasmin increase the risk for blood clots.

In a recently unsealed court document, former Food and Drug Administrator (FDA) commissioner David Kessler stated that the maker of the birth control drug Yasmin, Bayer, withheld internal data that suggested that Yasmin let to an increased risk of venous thromboembolism, also known as blood clots.

Thousands of lawsuits have been filed against Bayer for not providing adequate warnings about the risk of blood clots. Kessler has noted that Bayer withheld the information regarding the risk of blood clots while taking Yasmin before the drug was approved in 2001. Among the information withheld before approval were an internal study and two cases of patients developing blood clots. See the full news article.

The Law Offices of Larry H. Parker is actively pursuing legal action on behalf of injured women who were prescribed Yasmin and Yaz and were not properly warned of dangerous and potentially fatal blood clots. If you or a loved one has had an adverse heart event, including heart attack, stroke, or venous thromboembolism (blood clot), contact The Law Offices of Larry H. Parker today at (800) 333-0000 for a free consultation.